Monsanto Options Tekmira Delivery Technology in Agriculture | GenomeWeb

Tekmira Pharmaceuticals this week announced that it has signed a deal giving ag-bio firm Monsanto the option to license its proprietary lipid-based RNAi delivery technology for use in agricultural applications.

Over the four-year term of the option, Tekmira will provide Monsanto with lipid formulations in exchange for undisclosed payments to maintain the option. If Monsanto choses to exercise its option, it will pay an undisclosed fee to Tekmira and receive an exclusive, worldwide license to its delivery technology in agriculture.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.